Monte Rosa Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLUE and other ETFs, options, and stocks.About GLUE
Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
CEOMarkus Warmuth
CEOMarkus Warmuth
Employees134
Employees134
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2019
Founded2019
Employees134
Employees134
GLUE Key Statistics
Market cap1.12B
Market cap1.12B
Price-Earnings ratio56.61
Price-Earnings ratio56.61
Dividend yield—
Dividend yield—
Average volume1.53M
Average volume1.53M
High today—
High today—
Low today—
Low today—
Open price$17.61
Open price$17.61
Volume0.00
Volume0.00
52 Week high$19.17
52 Week high$19.17
52 Week low$3.50
52 Week low$3.50
Stock Snapshot
As of today, Monte Rosa Therapeutics(GLUE) shares are valued at $17.29. The company's market cap stands at 1.12B, with a P/E ratio of 56.61.
During the trading day, Monte Rosa Therapeutics(GLUE) stock saw an opening price of $17.61, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 1.53M.
The stock's 52-week range extends from a low of $3.50 to a high of $19.17.
The stock's 52-week range extends from a low of $3.50 to a high of $19.17.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own GLUE. This list is generated using Robinhood data, and it’s not a recommendation.